Activating <i>JAK1</i> mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinomaShuqun Yang, Douglas D. Fang|Oncotarget|2015Cited by 49
Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA MutationDouglas D. Fang, Todd VanArsdale|PLoS ONE|2013Cited by 44
Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer modelsDouglas D. Fang, Yifan Zhai|BMC Cancer|2022Cited by 31